Business
Guess which ASX 200 company co-founders just sold $118 million in shares
Image source: Getty Images
ASX 200 healthcare share Telix Pharmaceuticals Ltd (ASX: TLX) fell 9.4% to an intraday low of $27.52 as the market digested news of a $118 million off-market trade by the co-founders.
The radiopharmaceutical company’s CEO, Dr. Christian Behrenbruch, and former…
Continue Reading
